Dabomb Protein Biotech (ROCO:6578) ROCE %: -16.26% (As of Dec. 2025)

What is Dabomb Protein Biotech ROCE %?

Dabomb Protein Biotech ROCO:6578 +0.93% 61 ROCE % is -16.26% as of Dec. 2025. GuruFocus rates ROCO:6578 with a GF Score™ of 61/100 and a GF Value™ of NT$14.62 (Modestly Overvalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dabomb Protein Biotech's annualized ROCE % for the quarter that ended in Dec. 2025 was -16.26%.

Dabomb Protein Biotech (ROCO:6578) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dabomb Protein Biotech ROCE % Related Terms

Dabomb Protein Biotech ROCE % Historical Data

* Premium members only.

The historical data trend for Dabomb Protein Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dabomb Protein Biotech ROCE % Chart

Dabomb Protein Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-7.06

-3.90

-4.53

1.95

-5.89

Dabomb Protein Biotech Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
ROCE %	Get a 7-Day Free Trial															0.97	1.52	-6.22	-3.24	-16.26

61GF Score

Dabomb Protein Biotech Corp ROCO:6578

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Dabomb Protein Biotech ROCE % Calculation

Dabomb Protein Biotech's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-63.27	/	( ( (1315.271 - 178.976)	+	(1095.76 - 84.488) )	/ 2 )
	=	-63.27	/	( (1136.295	+	1011.272)	/ 2 )
	=	-63.27	/	1073.7835
	=	-5.89 %

Dabomb Protein Biotech's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Sep. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Sep. 2025 )		(Q: Dec. 2025 )
	=	-167.716	/	( ( (1190.637 - 138.653)	+	(1095.76 - 84.488) )	/ 2 )
	=	-167.716	/	( ( 1051.984	+	1011.272 )	/ 2 )
	=	-167.716	/	1031.628
	=	-16.26 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -16.26% mean?

Dabomb Protein Biotech (ROCO:6578) has a ROCE % of -16.26% as of Dec. 2025.

Is Dabomb Protein Biotech's ROCE % too high?

Dabomb Protein Biotech's current ROCE % is -16.26%. Overall, Dabomb Protein Biotech has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Dabomb Protein Biotech's ROCE % compare to KHC and GIS?

Dabomb Protein Biotech's ROCE % of -16.26% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Consumer Packaged Goods company?

The median ROCE % among Consumer Packaged Goods companies is 8.74, based on 1,936 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dabomb Protein Biotech's current ROCE % is -16.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Dabomb Protein Biotech stock overvalued right now?

Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$14.62, compared to a current price of NT$16.25 — trading 11.1% above its estimated fair value. The current ROCE % is -16.26%. Dabomb Protein Biotech's overall GF Score™ is 61/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current ROCE % is -16.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?

Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be overvalued. The current stock price of NT$16.25 is trading 11.1% above its estimated GF Value™ of NT$14.62. GuruFocus considers Dabomb Protein Biotech to be Modestly Overvalued.

Key valuation signals for ROCO:6578:

ROCE %: -16.26%
GF Value™: NT$14.62 vs. price of NT$16.25 (11.1% above fair value)
GF Score™: 61/100 with 1 warning sign

No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dabomb Protein Biotech Business Description

Industry Consumer Defensive Consumer Packaged Goods

Comparable Companies ROCO:6929 ROCO:4109 ROCO:2756 ROCO:6886 ROCO:6963 TPE:1220 ROCO:6968 ROCO:1294 TPE:1233 ROCO:8905 XSWX:NESN XPAR:BN BOG:NUTRESA TSE:2802 NSE:NESTLEIND SHSE:603288 KHC SHSE:600887 GIS SZSE:300999

Address No. 52, Industrial 3rd Road, Annan District, Tainan, TWN, 709

Website https://www.dabombprotein.com

Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.

61GF Score

Get the complete analysis for ROCO:6578

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.25

Price

NT$14.62

GF Value

View ROCO:6578 Analysis

See ROCE % data for all stocks →